Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Benner

Showing results (461-470 of 470) with videos related to

Pageof 47
Sort By:
You have reached the last page of results.This site can display upto 470 results.
Nature Biotechnology|October 11, 2008
The potential and challenges of nanopore sequencingDaniel Branton, David W Deamer, Andre Marziali, et al.
Leukemia|February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidineR F Schlenk, D Weber, W Herr, et al.
Environmental Health Perspectives|October 13, 2006
Saxitoxin puffer fish poisoning in the United States, with the first report of Pyrodinium bahamense as the putative toxin sourceJan H Landsberg, Sherwood Hall, Jan N Johannessen, et al.
Journal of Research of the National Institute of Standards and Technology|July 23, 2016
A Critical Evaluation of Interlaboratory Data on Total, Elemental, and Isotopic Carbon in the Carbonaceous Particle Reference Material, NIST SRM 1649aL A Currie, B A Benner, J D Kessler, et al.
Blood Cancer Journal|May 27, 2017
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemiaS Jaramillo, A Benner, J Krauter, et al.
ESMO Open|November 22, 2021
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trialC E Heilig, P Horak, S Kreutzfeldt, et al.
Leukemia|March 22, 2017
Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxideS Kayser, J Krzykalla, M A Elliott, et al.
Astrobiology|December 20, 2015
A Strategy for Origins of Life ResearchCaleb Scharf, Nathaniel Virgo, H James Cleaves, et al.
Pure and Applied Chemistry. Chimie Pure Et Appliquee|September 7, 2001
Redesigning nucleic acidsS A Benner, T R Battersby, B Eschgfaller, et al.
Astrobiology|May 30, 2020
Mars Extant Life: What's Next? Conference ReportB L Carrier, D W Beaty, M A Meyer, et al.
Pageof 47

Showing results (461-470 of 470) with videos related to

Sort By:
Pageof 47
You have reached the last page of results.This site can display upto 470 results.
Nature Biotechnology|October 11, 2008
The potential and challenges of nanopore sequencingDaniel Branton, David W Deamer, Andre Marziali, et al.
Leukemia|February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidineR F Schlenk, D Weber, W Herr, et al.
Environmental Health Perspectives|October 13, 2006
Saxitoxin puffer fish poisoning in the United States, with the first report of Pyrodinium bahamense as the putative toxin sourceJan H Landsberg, Sherwood Hall, Jan N Johannessen, et al.
Journal of Research of the National Institute of Standards and Technology|July 23, 2016
A Critical Evaluation of Interlaboratory Data on Total, Elemental, and Isotopic Carbon in the Carbonaceous Particle Reference Material, NIST SRM 1649aL A Currie, B A Benner, J D Kessler, et al.
Blood Cancer Journal|May 27, 2017
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemiaS Jaramillo, A Benner, J Krauter, et al.
ESMO Open|November 22, 2021
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trialC E Heilig, P Horak, S Kreutzfeldt, et al.
Leukemia|March 22, 2017
Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxideS Kayser, J Krzykalla, M A Elliott, et al.
Astrobiology|December 20, 2015
A Strategy for Origins of Life ResearchCaleb Scharf, Nathaniel Virgo, H James Cleaves, et al.
Pure and Applied Chemistry. Chimie Pure Et Appliquee|September 7, 2001
Redesigning nucleic acidsS A Benner, T R Battersby, B Eschgfaller, et al.
Astrobiology|May 30, 2020
Mars Extant Life: What's Next? Conference ReportB L Carrier, D W Beaty, M A Meyer, et al.
Pageof 47